More and more bacteria are nearly impervious to treatment. Could new approaches pick up where antibiotics leave off?
Martin Hirsch explores the role of a tenacious virus and the role of “fake news” in the great epidemic of 1918.
A century after the worst plague in history, researchers seek a universal flu vaccine to head off a repeat of the disaster.
The risk of dying from heart disease varies dramatically from one ZIP code to the next. Researchers are teasing apart the reasons why.
More physicians are prescribing a class of drugs called gabapentinoids to manage pain. Should we be worried?
Automated systems could soon take the guesswork out of managing diabetes. But will patients trust them with their lives?
What if drugs were released to the public earlier, then graded on their performance in the real world?
When patients demand more than science can provide, high-priced, ineffective treatments can reach the market.
A low ebb in funding for young scientists resists easy answers.
The first U.S. penis transplant didn’t save a life, but it vastly improved one, opening a frontier for complex transplants.
No Articles Found.